Selection from HEOR Bibliography

IMS logo
Search criteria
Country: Greece
 
Real-world treatment of patients diagnosed with serious infections due to carbapenem-resistant Gram-negative pathogens in Greek hospitals
Authors: Georgopoulos D1, Safarika A2, Ischaki E3, Filiou E4, Mantzarlis K5, Athanasopoulos D6, Fenoll R7, Sánchez E7, McCann E8
Affiliations: 1 University Hospital of Crete, Crete, Greece 2 National and Kapodistrian University of Athens, Athens, Greece 3 General Hospital of Athens Evaggelismos, Athens, Greece 4 National and Kapodistrian University of Athens, Medical School, General Hospital for Chest Diseases 'I Sotiria’ , Athens, Greece 5 University Hospital of Larissa, Larissa, Greece 6 Merck Sharp & Dohme Corp., Athens, Greece 7 IQVIA, Barcelona, Spain 8 Merck & Co., Inc., Kenilworth, NJ, US
Publications: 
ECCMID, Paris, France, 18-21 April 2020
Document Types: , Oral presentation
Countries: , Greece
Condition Year Language Analysis type
, Infectious disease 2020 English , Observational study, Retrospective Field Study
 
 
Resource utilisation associated with infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals
Authors: Durante Mangoni E1, Georgopoulos D2, Fernández-Martínez M3, Mastroianni C4, Viale P5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Perivoliotis E11 ,Bou Arevalo G12, Koutsoukou A13, Mantzarlis K14, Lozano V15, Gómez-Ulloa D16, Roset M16, McCann E17
Affiliations: 1 ‘L. Vanvitelli’ University, Monaldi Hospital, Naples, Italy 2 University Hospital of Crete, Crete, Greece 3 Marqués de Valdecilla University Hospital, Santander, Spain 4 Policlinico Umberto I, Rome, Italy 5 Policlinico S. Orsola-Malpighi, Bologna, Italy 6 University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’ , Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US
Publications: 
ECCMID, Paris, France, 18-21 April 2020
Document Types: , Oral presentation
Countries: , Greece, Italy, Spain
Condition Year Language Analysis type
, Infectious disease 2020 English , Observational study, Retrospective Field Study
 
 
Outcomes and predictors of outcomes of serious infections attributable to carbapenem-resistant Gram-negative pathogens in southern European hospitals
Authors: Georgopoulos D1, Durante Mangoni E2, Mastroianni C3, Viale P4, Arnáiz de las Revillas F5, Bassetti M6, Ferrer R7, Giamarellos-Bourboulis E8, Maseda E9, Salavert M10, Malachias S11, Bou Arevalo G12, Kyriakoudi A13, Tsolaki V14, Lopez D15, Gómez-Ulloa D16, Lara N16, McCann E17
Affiliations: 1 University Hospital of Crete, Crete, Greece 2 ‘L. Vanvitelli’, Monaldi Hospital, Naples, Italy 3 Policlinico Umberto I, Rome, Italy 4 Policlinico S. Orsola-Malpighi, Bologna, Italy 5 Marqués de Valdecilla University Hospital, Santander, Spain 6University of Genova and Policlinico San Martino, Genova, Italy 7 Vall d'Hebron University Hospital, Barcelona, Spain 8 National and Kapodistrian University of Athens, Athens, Greece 9 University Hospital La Paz, Madrid, Spain 10 Hospital Universitario y Politécnico de La Fe, València, Spain 11 Evaggelismos General Hospital, Athens, Greece 12 Hospital Universitario La Coruña, La Coruña, Spain 13 National and Kapodistrian University and General Hospital for Chest Diseases 'I Sotiria’, Athens, Greece 14 University Hospital of Larissa, Larisa, Greece 15 Merck Sharp & Dohme, Madrid, Spain 16 IQVIA, Barcelona, Spain 17 Merck & Co., Inc., Kenilworth, NJ, US
Publications: 
ECCMID, Paris, France, 18-21 April 2020
Document Types: , Oral presentation
Countries: , Greece, Italy, Spain
Condition Year Language Analysis type
, Infectious disease 2020 English , Observational study, Retrospective Field Study
 
 
EVALUATION OF THE EFFECTIVENESS OF RISK MINIMISATION MEASURES TARGETING PHYSICIANS ON PRESCRIBING PRACTICES OF THIOCOLCHICOSIDE (TCC) CONTAINING MEDICINAL PRODUCTS FOR SYSTEMIC USE
Authors: Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure Kürzinger, Hanka de Voogd, Massoud Toussi
Affiliations: Real World Evidence Solutions, IQVIA, France; Global Pharmacovigilance – Global Safety Sciences - Risk Management, Sanofi; Epidemiology and Benefit Risk Evaluation, Sanofi; Global Clinical Sciences; Vaccines & Anti-Infectives, Mylan, The Netherlands
Publications: 
Poster presented at: 35th International Conference an Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Pennsylvania Convention Center Philadelphia, Pennsylvania August 24-28, 2019
Document Types: , Poster
Countries: , France, Greece, Italy, Portugal
Abstract: https://www.coodoc.com/pages/p1819-Thiocholchicoside-ICPE-2019
Condition Year Language Analysis type
, Health policy, Musculoskeletal disease 2019 English , Survey research
 
 
Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use
Authors: Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M
Affiliations: IQVIA
Publications: 
Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372
Document Types: , Article
Countries: , France, Greece, Italy, Portugal
Abstract: https://www.omicsonline.org/open-access/evaluation-of-the-effectiveness-of-risk-minimisation-measures-targeting-physicians-on-prescribing-practices-of-thiocolchicoside-co-2161-1165-1000372-108159.html
Condition Year Language Analysis type
, Musculoskeletal disease, Rheumatology, Risk Management & REMS 2019 English , Survey research
 
 
Patient and caregiver indirect costs after acute cardiovascular events in Europe.
Authors: Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5
Affiliations: 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium
Publications: 
ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
Document Types: , Oral presentation
Countries: , Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84816?pdfid=58963
Condition Year Language Analysis type
, Cardiovascular disease, Health economics 2018 English , Burden of illness, Cost of illness
 
 
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model
Authors: Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7
Affiliations: 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany
Publications: 
JHEOR 2017;5(1):89-108
Document Types: , Article
Countries: , Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK
Condition Year Language Analysis type
, Immunology and Vaccination, Infectious disease, Respiratory disease 2017 English , Epidemiological study, Public Health
 
 
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature.
Authors: Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1.
Affiliations: 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden.
Publications: 
Clinical Epidemiology
Document Types: , Article
Countries: , Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK
Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/
Condition Year Language Analysis type
, Oncology 2016 English , Literature Review
 
 
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study.
Authors: Peyrin-Biroulet L1, Van Assche G2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations: 1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. Electronic address: peyrinbiroulet@gmail.com. 2Division of Gastroenterology, University Hospitals Leuven, Leuven Belgium. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom. 10IMS Health, Real World Evidence Solutions, Spain. 11Merck & Co., Inc., Kenilworth, NJ, United States
Publications: 
Dig Liver Dis. 2016 Jun;48(6):601-7.
Document Types: , Article
Countries: , Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK
Condition Year Language Analysis type
, Gastrointestinal disorders 2016 English , Burden of illness, Patient questionnaire, Survey research
 
 
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study
Authors: Van Assche G1, Peyrin-Biroulet L2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11.
Affiliations: 1Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.vanassche@uzleuven.be. 2Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica and Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK. 10IMS Health, Real World Evidence Solutions, Barcelona, Spain. 11Merck & Co., Inc., Rahway, NJ, United States.
Publications: 
Dig Liver Dis. 2016 Jun;48(6):592-600
Document Types: , Article
Countries: , Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK
Condition Year Language Analysis type
, Gastrointestinal disorders 2016 English , Burden of illness, Patient questionnaire
 
 
Liver transplant associated with paracetamol overdose: results from the seven-country SALT study
Authors: Sinem Ezgi Gulmez,1 Dominique Larrey,2 Georges- Philippe Pageaux,2 Jacques Bernuau,3 Franco Bissoli,4 Yves Horsmans,5 Douglas Thorburn,6 P. Aiden McCormick,7 Bruno Stricker,8 Massoud Toussi,9 Séverine Lignot-Maleyran,1 Sophie Micon,1 Fatima Hamoud,1 Régis Lassalle,1 Jérémy Jové,1 Patrick Blin1 & Nicholas Moore1
Affiliations: 1CIC Bordeaux CIC1401 Pharmaco-épidémiologie, Université de Bordeaux, F-33076 Bordeaux, France, 2CHU St Eloi Hospital, Liver Unit, Montpellier, France, 3Beaujon Hospital, Liver Unit, Clichy, France, 4Department of Internal Medicine, Clinica San Gaudenzio, Novara, Italy, 5Department of Gastroenterology, Louvain Catholic University, Louvain, Belgium, 6Liver Unit, Royal Free NHS Trust, London, UK, 7Liver Unit, St Vincent’s University Hospital and University College Dublin, Dublin, Ireland, 8Department of Epidemiology, Erasmus University, Rotterdam, Netherlands and 9IMSHealth, Real World Evidence Solutions, France
Publications: 
British Journal of Clinical Pharmacology 2015
Document Types: , Article
Countries: , France, Greece, Ireland, Italy, Netherlands, Portugal, UK
Condition Year Language Analysis type
, Drug safety, Public Health 2015 English , Epidemiological study
 
 
Survey on appropriateness of use of nimesulide in nine European countries
Authors: Franchi S1, Heiman F2, Visentin E2, Sacerdote P1.
Affiliations: 1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. 2Cegedim Strategic Data Medical Research Srl, Milan, Italy.
Publications: 
Drug, Healthcare and Patient Safety 2015:7 51-55
Document Types: , Article
Countries: , Bulgaria, Czech, Greece, Hungary, Italy, Poland, Portugal, Romania, Slovakia
Condition Year Language Analysis type
, Pain 2015 English , Survey research
 
 
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study.
Authors: Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14.
Affiliations: 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 2Department of Rheumatology, CHU Strasbourg, Strasbourg, France. 3University of Cologne, Cologne, Germany. 4L Sacco University Hospital, Milan, Italy. 5University of Montreal, Montreal, Canada. 6Facultad de Medicina, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain. 7Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. 8Department of Rheumatology, University of Liverpool, Liverpool, UK. 9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. 10Hellenic Foundation for Rheumatological Research, Athens, Greece. 11Quintiles, Rockville, Maryland, USA. 12F Hoffmann-La Roche Ltd, Basel, Switzerland. 13Genentech Inc, San Francisco, California, USA. 14University Hospital of Geneva, Geneva, Switzerland.
Publications: 
Ann Rheum Dis. 2015 Jun;74(6):979-84
Document Types: , Article
Countries: , Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431330/
Condition Year Language Analysis type
, Comparative Effectiveness & Health Technology Assessment, Rheumatology 2015 English , Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles
 
 
Quantification of switching trends in the Greek pharmaceutical market during the period of crisis
Authors: Ollandezos M1, Charitonidis S2, Papadopoulos K1, Katsoulakis M2, Kofinas K2, Kyriopoulos J3
Affiliations: 1Pan Hellenic Union of Pharmaceutical Industry, Athens, Greece, 2IMS Health Hellas, Athens, Greece, 3National School of Public Health, Athens, Greece
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Greece
Condition Year Language Analysis type
, Health policy 2014 English , Methodology
 
 
Generic penetration within top-10 genericized molecules – Greece versus major European countries
Authors: Charitonidis S1, Kofinas K1, Katsoulakis M1, Papadopoulos K2, Ollandezos M2, Kyriopoulos J3
Affiliations: 1IMS Health Hellas, Athens, Greece, 2Pan Hellenic Union of Pharmaceutical Industry, Athens, Greece, 3National School of Public Health, Athens, Greece
Publications: 
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Types: , Poster
Countries: , Greece
Condition Year Language Analysis type
, Health policy 2014 English , Pricing & Reimbursement
 
 
Primary prevention of cardiovascular disease in Greece: Greek results of the EURIKA study.
Authors: Moses Elisaf1, Emmanouil Tzouvelekis2, Nikos Nikas2; on behalf of the Greek EURIKA Investigators
Affiliations: 1 Department of Internal Medicine, University Hospital of Ioannina, Ioannina, 2 Medical Department, AstraZeneca SA, Athens, Greece
Publications: 
Hellenic J Cardiol. 2014 May-Jun;55(3):217-26
Document Types: , Article
Countries: , Greece
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24862614
Condition Year Language Analysis type
, Cardiovascular disease 2014 English , Survey research
 
 
Economic evaluation of Rivaroxaban in stroke prevention among patients with Atrial Fibrillation in Greece
Authors: Kourlaba G1, Maniadakis N1, Andrikopoulos G2, Vardas P3, Llyod A4, Asukai Y4, Evers T5
Affiliations: 1National School of Public Health, Athens, Greece, 2Henry Dunant Hospital, Athens, Greece, 3University of Crete, Heraklion, Crete , Greece, 4IMS Health, London, UK, 5Bayer Schering Pharma AG, Wuppertal, Germany
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Greece
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx
Condition Year Language Analysis type
, Cardiovascular disease 2012 English , Economic evaluation
 
 
Economic evaluation of Rivaroxaban in the treatment of Deep Vein Thrombosis in Greece
Authors: Kourlaba G1, Maniadakis N1, Giannoukas A2, Katsamouris A3, Katsenis K4, Lazarides M5, Matsagas M6, Lowin J7, McLeod EJ8, Bamber L9
Affiliations: 1National School of Public Health, Athens, Greece, 2University of Thessaly, Larissa, Greece, 3University of Crete, Heraklion, Crete, Greece, 4University of Athens, Athens, Greece, 5Democritus University, Thrace, Greece, 6University of Ioannina, Ioannina, Greece, 7IMS Health, London , UK, 8IMS Health, London, UK, 9Bayer Pharma AG, Wuppertal, Germany
Publications: 
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany
Document Types: , Poster
Countries: , Greece
Abstract: http://www.ispor.org/congresses/Berlin1112/Posters2.aspx
Condition Year Language Analysis type
, Cardiovascular disease 2012 English , Economic evaluation
 
 
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.
Authors: Jose´ R. Banegas 1,2*, Esther Lo´pez-Garcı´a 1,2, Jean Dallongeville3, Eliseo Guallar 4,5,6,7, Julian P. Halcox8, Claudio Borghi 9, Elvira L. Masso´-Gonza´lez 10, Francisco J. Jime´nez 11, Joep Perk12, Philippe Gabriel Steg13, Guy De Backer 14,and Fernando Rodrı´guez-Artalejo1,2
Affiliations: 1 Department of Preventive Medicine and Public Health, School of Medicine, Universidad Auto´noma de Madrid/IdiPAZ, Avda Arzobispo Morcillo, 2, 28029 Madrid, Spain; 2 CIBER of Epidemiology and Public Health, Madrid, Spain; 3 Inserm U 744, Institut Pasteur de Lille, 59019 Lille Cedex, France; 4 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 5 Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 6 Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 7 Department of Cardiovascular Epidemiology and Population Genetics, National Center for Cardiovascular Research (CNIC), Madrid 28029, Spain; 8 Wales Heart Research Institute, Cardiff University, Heath Park, Cardiff CF14 4XN, UK; 9 Department of Internal Medicine, Aging and Clinical Nephrology, University of Bologna, Bologna, Italy; 10Medical Department, AstraZeneca Farmace´utica Spain, S.A., 28003 Madrid, Spain; 11Medical Department, AstraZeneca Europe, 1935 Zaventem, Belgium; 12School of Health and Caring Sciences, Linnaeus University, 391 82 Kalmar, Sweden; 13INSERM U 698, Assistance Publique–Hoˆpitaux de Paris and Universite´ Paris-Diderot, Paris, France; and 14Department of Public Health, University of Gent, 9000 Gent, Belgium
Publications: 
Eur Heart J. 2011 Sep;32(17):2143-52
Document Types: , Article
Countries: , Austria, Belgium, France, Germany, Greece, Norway, Spain, Sweden, Switzerland, Turkey, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21471134
Condition Year Language Analysis type
, Cardiovascular disease 2011 English , Observational study, Prospective study
 
 
Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe.
Authors: Papageorgiou G1, Cañas F, Zink M, Rossi A.
Affiliations: 1Department of Psychiatry, Evangelismos General Hospital
Publications: 
Eur Psychiatry. 2011 Mar;26(1 Suppl 1):17-28. doi: 10.1016/S0924-9338(11)71710-2.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21440220
Condition Year Language Analysis type
, Neurological disorders 2011 English , Survey research
 
 
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study.
Authors: Guallar E, Banegas JR, Blasco-Colmenares E, Jiménez FJ, Dallongeville J, Halcox JP, Borghi C, Massó-González EL, Tafalla M, Perk J, De Backer G, Steg PG, Rodríguez-Artalejo F.
Affiliations: 
Publications: 
BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704.
Document Types: , Article
Countries: , Austria, Belgium, France, Germany, Greece, Norway, Russian Federation, Spain, Sweden, Switzerland, Turkey, UK
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21923932
Condition Year Language Analysis type
, Cardiovascular disease 2011 English , Observational study, Prospective study
 
 
Factors associated with hospitalisation of patients with schizophrenia in four European countries.
Authors: Gorwood P1.
Affiliations: 1CMME, Sainte-Anne Hospital, University Paris Descartes
Publications: 
Eur Psychiatry. 2011 May;26(4):224-30. doi: 10.1016/j.eurpsy.2011.02.012. Epub 2011 Mar 23.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21429717
Condition Year Language Analysis type
, Neurological disorders 2011 English , Survey research
 
 
Patients with schizophrenia : results of a physician-based survey conducted in four European countries (Germany, Greece, Italy and Spain).
Authors: Gorwood P1.
Affiliations: 1CMME, Sainte-Anne Hospital, University Paris Descartes
Publications: 
Eur Psychiatry. 2011 Mar;26(1 Suppl 1):1.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf
Condition Year Language Analysis type
, Neurological disorders 2011 English , Survey research
 
 
Use of ziprasidone in patients with schizophrenia in four European countries.
Authors: Montes JM1.
Affiliations: 1Hospital del Sureste, Arganda del Rey, Spain
Publications: 
Eur Psychiatry. 2011 Mar;26(1 Suppl 1):29-37. doi: 10.1016/S0924-9338(11)71711-4.
Document Types: , Article
Countries: , Germany, Greece, Italy, Spain
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21440221
Condition Year Language Analysis type
, Neurological disorders 2011 English , Survey research
 
 
The relative cost-effectiveness of the fentanyl HCL patient-activated transdermal system (ITS) in acute post-operative pain management (POPM) in Greece.
Authors: Yfantopoulos I, Papanicolaou S, Papagiannopoulou V, Van Bellinghen LA, Annemans L
Affiliations: 
Publications: 
ISPOR 10th Annual European Congress, 2007, October 20-23, Dublin, Ireland
ISPOR 2007 10th Annual European Congress
Document Types: , Abstract
Countries: , Belgium, Greece
Condition Year Language Analysis type
, Clinical practice, Health economics 2007 English , Cost effectiveness
 
 
Copyright 2024 IMS Health Incorporated. All rights reserved.